started · updated
Machine learning applied to Alzheimer's biomarkers in Down syndrome
Researchers are applying machine learning techniques to blood-based biomarkers to study Alzheimer's disease in individuals with Down syndrome. This study, involving multiple academic institutions, aims to improve the understanding and potential diagnosis of Alzheimer's within this specific population through advanced computational analysis of biological markers.
Entities
University of California Irvine · University of North Texas Health Science Center at Fort Worth · University of Pittsburgh · University of Wisconsin-Madison · Washington University School of Medicine in St. Louis